1. Home
  2. CUBI vs EVO Comparison

CUBI vs EVO Comparison

Compare CUBI & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUBI
  • EVO
  • Stock Information
  • Founded
  • CUBI 1994
  • EVO 1993
  • Country
  • CUBI United States
  • EVO Germany
  • Employees
  • CUBI N/A
  • EVO N/A
  • Industry
  • CUBI Major Banks
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • CUBI Finance
  • EVO Health Care
  • Exchange
  • CUBI Nasdaq
  • EVO Nasdaq
  • Market Cap
  • CUBI 2.3B
  • EVO 1.2B
  • IPO Year
  • CUBI 2012
  • EVO 2021
  • Fundamental
  • Price
  • CUBI $66.96
  • EVO $3.50
  • Analyst Decision
  • CUBI Buy
  • EVO Buy
  • Analyst Count
  • CUBI 8
  • EVO 2
  • Target Price
  • CUBI $69.88
  • EVO $5.40
  • AVG Volume (30 Days)
  • CUBI 369.1K
  • EVO 44.3K
  • Earning Date
  • CUBI 10-30-2025
  • EVO 11-05-2025
  • Dividend Yield
  • CUBI N/A
  • EVO N/A
  • EPS Growth
  • CUBI N/A
  • EVO N/A
  • EPS
  • CUBI 4.05
  • EVO N/A
  • Revenue
  • CUBI $596,459,000.00
  • EVO $912,894,891.00
  • Revenue This Year
  • CUBI $16.04
  • EVO $0.43
  • Revenue Next Year
  • CUBI $6.11
  • EVO $9.72
  • P/E Ratio
  • CUBI $16.54
  • EVO N/A
  • Revenue Growth
  • CUBI N/A
  • EVO N/A
  • 52 Week Low
  • CUBI $40.75
  • EVO $2.84
  • 52 Week High
  • CUBI $72.51
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • CUBI 48.16
  • EVO 43.62
  • Support Level
  • CUBI $66.88
  • EVO $3.43
  • Resistance Level
  • CUBI $69.05
  • EVO $3.55
  • Average True Range (ATR)
  • CUBI 1.59
  • EVO 0.08
  • MACD
  • CUBI -0.56
  • EVO 0.02
  • Stochastic Oscillator
  • CUBI 10.19
  • EVO 63.64

About CUBI Customers Bancorp Inc

Customers Bancorp Inc is a bank holding company engaged in banking activities. It provides financial products and services to small and middle-market businesses, not-for-profits, and consumers. The company operates in Lending Activities, Commercial Lending, Consumer Lending, Private Banking, Deposit Products, Other Funding Sources and Financial Products and Services. The majority of revenue is derived from commercial lending.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: